Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorescence PCR quantification of cyclin D1 expression.

Kojo S J Elenitoba-Johnson1, Sandra D Bohling, Stephen D Jenson

  • 1Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA. kojo.elenitobaj@path.utah.edu

The Journal of Molecular Diagnostics : JMD
|May 3, 2002
PubMed
Summary

Quantitative real-time RT-PCR reliably distinguishes mantle cell lymphoma (MCL) from chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) by measuring cyclin D1 mRNA expression. MCL cases show significantly higher cyclin D1 mRNA levels than CLL/SLL.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

medRxiv : the preprint server for health sciences·2026
Same author

X-linked SEPTIN6-related congenital neutropenia and B cell deficiency.

Journal of human immunity·2026
Same author

The miR-155-5p/SOCS1/NF-κB Axis Regulates Airway Smooth Muscle Dysfunction and is a Potential Therapeutic Candidate of Chronic Obstructive Pulmonary Disease.

Inflammation·2026
Same author

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Blood cancer journal·2026
Same author

SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities.

Cancer discovery·2026
Same author

Breast-implant associated unicentric castleman disease: a case report.

Current problems in cancer. Case reports·2026

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Cyclin D1 is a key cell cycle regulator implicated in various cancers.
  • Accurate assessment of cyclin D1 mRNA expression is crucial for diagnosing hematological malignancies.

Purpose of the Study:

  • To evaluate the utility of quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) for assessing cyclin D1 mRNA expression.
  • To differentiate between various hematological neoplasms, particularly mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Main Methods:

  • Continuous fluorescence monitoring using fluorescently labeled, sequence-specific hybridization probes.
  • Analysis of cyclin D1 mRNA expression in 14 cell lines, 11 reactive lymphoid tissues, and 57 primary hematopoietic neoplasms.

Related Experiment Videos

  • Normalization using a beta-globin mRNA transcript to ensure RNA integrity and accurate quantification.

    • Main Results:

    • Mantle cell lymphoma (MCL) cases exhibited substantially higher cyclin D1 mRNA levels compared to other lymphoproliferative disorders.
    • Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) cases showed cyclin D1 mRNA levels two to three orders of magnitude lower than MCL.
    • Non-hematopoietic neoplasms displayed comparable or higher cyclin D1 mRNA levels than MCL.

    Conclusions:

    • Quantitative real-time RT-PCR is a simple, rapid, and accurate method for assessing cyclin D1 expression.
    • This technique reliably distinguishes MCL from CLL/SLL, despite not being entirely specific for MCL.